CCC
PFE icon

Compass Capital Corp’s Pfizer PFE Stock Holding History

Compass Capital Corp’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.04M Sell
48,314
-3,100
-6% -$81.1K 0.34% 70
2026
Q1 		$1.07M Sell
51,414
-7,662
-13% -$204K 0.38% 68
2025
Q4 		$1.41M Buy
59,076
+9,375
+19% +$236K 0.54% 53
2025
Q3 		$1.07M Sell
49,701
-371
-0.7% -$9.16K 0.47% 60
2025
Q2 		$1.25M Hold
50,072
– – 0.59% 50
2025
Q1 		$1.25M Buy
50,072
+615
+1% +$16.1K 0.66% 47
2024
Q4 		$1.29M Buy
+49,457
New +$1.34M 0.5% 65

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Compass Capital Corp's PFE Position: Q2 2026 in Review

Compass Capital Corp reduced its Pfizer (PFE) stake by 6% in Q2 2026, selling an estimated $81.1K and leaving 48,314 shares worth $1.04M. The position accounts for 0.34% of the portfolio, ranked #70.

Compass Capital Corp first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.41M in Q4 2025. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Compass Capital Corp held 48,314 shares of Pfizer worth $1.04M as of Q2 2026.
  • Compass Capital Corp sold 3,100 Pfizer shares in Q2 2026, an estimated $81.1K.
  • Pfizer made up 0.34% of Compass Capital Corp's portfolio in Q2 2026, its #70 holding.
  • Compass Capital Corp first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Compass Capital Corp's Pfizer position peaked at $1.41M in Q4 2025.
  • 2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Compass Capital Corp's 13F filing for Q2 2026, filed 13 Aug 2026.